March 02, 2026

Pediatricians at the Perioperative Helm

Pediatricians “uniquely positioned” to take active role in preanesthesia planning, says revised American Academy of Pediatrics report

Conexiant

March 01, 2026

The Benefits of Fluoride: Addressing Public Concern and Supporting Topical Use

Recent studies raise questions about fluoride's safety in drinking water, despite its long-standing role in dental health, highlighting a shift towards fluoride toothpaste as a standard preventive measure.

Compendium

February 26, 2026

AHA Issues Pediatric Hypertriglyceridemia Statement

The scientific statement defines pancreatitis and atherosclerotic cardiovascular disease risk thresholds and outlines causes and management in youths.

Conexiant

February 18, 2026

Building Better Oral Suspensions for Pediatric & Real-World Use

Greg Thomas, Kiel Laboratories’ Vice President of R&D, discusses oral suspensions, excipients, and patient-centered formulation

The Medicine Maker

February 17, 2026

VA DOD Updates Asthma Framework

The 2025 US Department of Veterans Affairs and US Department of Defense asthma guideline introduces 21 evidence-based recommendations for primary care, redefining stepwise treatment, comorbidity management, and reliever strategy.

Conexiant

February 11, 2026

Fetal Spina Bifida Surgery Advances: Fewer Risks, Better Outcomes

At the Fetal Care Center, WashU Medicine surgeons perform both open and fetoscopic myelomeningocele repair, offering families results that exceed benchmarks

Barnes-Jewish

February 09, 2026

Managing Idiopathic Acute Pancreatitis

Expert panel weighs evidence for genetic testing, cholecystectomy, and ERCP in patients with unexplained acute pancreatitis amid limited guideline direction.

Conexiant

January 29, 2026

Can a BiTE Immunotherapy Improve Survival in Young Patients with High-Risk Kinase-Driven B-ALL Subtypes?

Two genetic subtypes of childhood B-cell acute lymphoblastic leukemia (B-ALL) have long been associated with inferior treatment outcomes: Philadelphia chromosome-positive (Ph+) and ABL-class Philadelphia chromosome-like (Ph-like) B-ALL.

Roswell Park Comprehensive Cancer Center

January 26, 2026

Myopia: Evidence That Endures

Why robust long-term clinical myopia control evidence is crucial for protecting children’s vision

The Ophthalmologist

January 09, 2026

Recombinant ADAMTS13: An Enzyme Replacement Therapy for the Management of Congenital Thrombotic Thrombocytopenic Purpura

The FDA's approval of recombinant ADAMTS13 marks a significant advancement in managing congenital thrombotic thrombocytopenic purpura, ensuring better care for patients suffering from this rare condition.

JADPRO